MedPath

Intestinal permeability in glomerular diseases

Not Applicable
Conditions
N05
N00-N08
Unspecified nephritic syndrome
Glomerular diseases
Registration Number
DRKS00021533
Lead Sponsor
niversitätsklinikum der RWTH Aachen
Brief Summary

The present single center pilot study suggests that disturbed intestinal permeability is common in patients with glomerular diseases and is not specific for IgAN.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
62
Inclusion Criteria

Biopsy-proven primary glomerulonephritis or no prior renal disease (healthy controls). Able to consent.

Exclusion Criteria

History of chronic gastrointestinal diseases, signs of acute infection, diabetes mellitus, end-stage renal disease, or intake of non-steroidal anti-inflammatory drugs (NSAID) during the last 48 hours prior to the study as well as pregnant and breast-feeding patients

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary excretion of the various sugars (lactulose, L-rhamnose, sucralose and erythritol) at 2, 5, 24 hrs after oral ingestion
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath